Product Information
NIFEDIPINE ER 30 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1301 per EA under NDC 00904720861. Its NADAC has been published 219 times since Jul 27, 2022.
FDA first approved this application on Apr 3, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904720861
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA203126FDA Approved
4/3/2014
TE Code
AB2
On Market Since
11/1/2014
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE ER 30 MG TABLET has been published 219 times since Jul 27, 2022, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1301 per EA |
|---|---|
| All-time high | $0.1491 (Aug 10, 2022) |
| All-time low | $0.0941 (Nov 20, 2024) |
| 52-week high | $0.1365 |
| 52-week low | $0.1094 |
| Median price | $0.1197 |
| Average price | $0.1221 |
| Largest weekly change | -25.1% (Apr 17, 2024) |
| Weeks tracked | 219 |
| Tracking since | Jul 27, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE ER 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE ER 30 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1301 per EA (NDC 00904720861), effective Sep 30, 2026.
How has the price of NIFEDIPINE ER 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE ER 30 MG TABLET has declined 12.8%. It has been tracked across 219 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE ER 30 MG TABLET?
Since Jul 27, 2022, the NADAC for NIFEDIPINE ER 30 MG TABLET has ranged from a low of $0.0941 (Nov 20, 2024) to a high of $0.1491 (Aug 10, 2022), with a median of $0.1197 per EA.
Are there cheaper alternatives to NIFEDIPINE ER 30 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIFEDIPINE ER 30 MG TABLET, is $0.1006 per EA — about 23% below NIFEDIPINE ER 30 MG TABLET.
Who manufactures NIFEDIPINE ER 30 MG TABLET?
NIFEDIPINE ER 30 MG TABLET (NDC 00904720861) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.